OmniAb, Inc. logo

OmniAb, Inc.


Overview | Financials
Company Name OmniAb, Inc.
Symbol OABI
Currency USD
Price 4.66
Market Cap 545,807,370
Dividend Yield 0%
52-week-range 3.56 - 6.715
Industry Biotechnology
Sector Healthcare
CEO Mr. Matthew W. Foehr

An error occurred while fetching data.

About OmniAb, Inc.

OmniAb, Inc., a biotechnology company, provides therapeutic antibody discovery technologies in the United States. The company's discovery platform provides industry partners access to the diverse antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform is the biological intelligence of proprietary transgenic animals, including OmniRat, OmniChicken,

Related Stocks


Numbers are in millions USD

Numbers are in millions USD